The Centers for Disease Control and Prevention (CDC) has updated its clinician guidance webpage to reflect the most current information based on the investigating into the multistate fungal meningitis outbreak among patients who received contaminated steroid injections.

The page contains updates to FAQs, case definitions, and information on diagnostic testing. Three interim treatment guidance documents also have been updated.

CDC urges clinicians to contact patients who have received medicines associated with 3 lots of preservative-free methylprednisolone acetate from the New England Compounding Center that were recalled on September 26. The potentially contaminated injections were given starting May 21.